b12 injections to buy Hydroxocobalamin (B12) Injection, 2mg/mL AOD-9604 failed its FDA AOD9604 MIC B12 from Fitish Treatment:12 Months
AOD-9604 failed its FDA trials and got dismissed as ineffective. the actual story is more specific — and more instructive. 🧩 the compound is a fragment of human growth hormone, isolated from
Each year, an estimated 300,000 adults in the United States die of causes related to obesity [2] According to the guidelines of the National Institute of Health (NIH) regarding the treatment of obesity, “weight loss drugs approved by the FDA [US Food and Drug Administration] may only be used as part of a comprehensive weight loss program, including dietary therapy and physical activity, for patients with a BMI [body mass index] of ≥30 with no concomitant obesity-related risk factors or diseases, and for patients with a BMI of ≥27 with concomitant obesity-related risk factors or diseases”[3].The risk factors and diseases considered important enough to warrant pharmacotherapy at a BMI of 27--29.9 are hypertension, dyslipidemia, coronary heart disease (CHD), type 2 diabetes, and sleep apnea [3]
AOD9604
Treatment:12 Months
For comprehensive information on peptide side effect profiles in research contexts, see our peptide side effects guide
MIC B12 from Fitish RX
